title: Timing of NT-pro-BNP sampling for predicting adverse outcome after acute pulmonary embolism.
authors.forename: Frederikus A
authors.initials: FA
authors.lastname: Klok
authors.forename: Noortje
authors.initials: N
authors.lastname: van der Bijl
authors.forename: Inge C M
authors.initials: IC
authors.lastname: Mos
authors.forename: Albert
authors.initials: A
authors.lastname: de Roos
authors.forename: Lucia J M
authors.initials: LJ
authors.lastname: Kroft
authors.forename: Menno V
authors.initials: MV
authors.lastname: Huisman
mesh_terms: D000368:Aged; D015415:Biomarkers / Q000097:blood; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D032383:Myocytes, Cardiac / Q000378:metabolism* / Q000473:pathology; D020097:Natriuretic Peptide, Brain / Q000096:biosynthesis* / Q000097:blood / Q000235:genetics; D010446:Peptide Fragments / Q000096:biosynthesis* / Q000097:blood / Q000235:genetics; D011379:Prognosis; D011655:Pulmonary Embolism / Q000097:blood / Q000175:diagnosis* / Q000453:epidemiology* / Q000401:mortality; D015983:Selection Bias; D016019:Survival Analysis; D016896:Treatment Outcome; D016276:Ventricular Function
chemical_list: D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain